Search research articles
Contact Us
Filters
Showing results (111-120 of 260) with videos related to
Page
of 26
Sort By:
The American Journal of Cardiology
|
December 1, 2006
Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure
Steve S Lee, Matthew J Price, Garrett B Wong, et al.
American Heart Journal
|
April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial
Matthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions
|
May 23, 2020
Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study
Hiroyuki Arashi, Yuhei Kobayashi, Matthew J Price, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2017
ACIST-FFR Study (Assessment of Catheter-Based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement)
William F Fearon, Jeffrey W Chambers, Arnold H Seto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 24, 2017
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial
Matthew J Price, Richard A Shlofmitz, Douglas J Spriggs, et al.
JACC. Clinical Electrophysiology
|
November 30, 2023
Inotropes to Differentiate Dense Spontaneous Echo Contrast From Thrombus in the Left Atrial Appendage
Amitabh C Pandey, Christine P Shen, Edward Chu, et al.
Journal of the American College of Cardiology
|
February 21, 2006
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization
Matthew J Price, Ecaterina Cristea, Neil Sawhney, et al.
Circulation
|
August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial
Matthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
JACC. Cardiovascular Interventions
|
July 22, 2017
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
Matthew J Price, Shigeru Saito, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study
Matthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 260) with videos related to
Sort By:
Page
of 26
The American Journal of Cardiology
|
December 1, 2006
Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure
Steve S Lee, Matthew J Price, Garrett B Wong, et al.
American Heart Journal
|
April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial
Matthew J Price, Peter B Berger, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions
|
May 23, 2020
Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study
Hiroyuki Arashi, Yuhei Kobayashi, Matthew J Price, et al.
Circulation. Cardiovascular Interventions
|
December 17, 2017
ACIST-FFR Study (Assessment of Catheter-Based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement)
William F Fearon, Jeffrey W Chambers, Arnold H Seto, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 24, 2017
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial
Matthew J Price, Richard A Shlofmitz, Douglas J Spriggs, et al.
JACC. Clinical Electrophysiology
|
November 30, 2023
Inotropes to Differentiate Dense Spontaneous Echo Contrast From Thrombus in the Left Atrial Appendage
Amitabh C Pandey, Christine P Shen, Edward Chu, et al.
Journal of the American College of Cardiology
|
February 21, 2006
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization
Matthew J Price, Ecaterina Cristea, Neil Sawhney, et al.
Circulation
|
August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial
Matthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
JACC. Cardiovascular Interventions
|
July 22, 2017
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
Matthew J Price, Shigeru Saito, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology
|
May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study
Matthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.
Page
of 26